PBS listing for new-generation epilepsy drug

The first in a new class of drugs to treat partial onset seizure could offer a solution to drug-resistant epilepsy, says a leading Australian neurologist.

Perampanel, which has been approved for reimbursement on the PBS, is the only available anti-epilepsy drug (AED) to selectively target specific receptors implicated in the spread of seizures. It is indicated as an adjunctive treatment for patients who have not responded to previous treatment.

Professor Terence O’Brien (pictured), a consultant neurologist and head of the epilepsy